Results 41 to 50 of about 133 (126)

A PD‐1highCD4+ T Cell Population With a Cytotoxic Phenotype is Associated With Interstitial Lung Disease in Systemic Sclerosis

ACR Open Rheumatology, Volume 6, Issue 7, Page 429-439, July 2024.
Objective T cells contribute to tissue injury in systemic sclerosis (SSc), yet the specific T cell subsets expanded in patients with SSc remain incompletely defined. Here we evaluated specific phenotypes and functions of peripheral helper T (Tph) and follicular helper T (Tfh) cells, which have been implicated in autoantibody production, and assessed ...
Mehreen Elahee, Alisa A. Mueller, Runci Wang, Kathryne E. Marks, Takanori Sasaki, Ye Cao, Andrea Fava, Paul F. Dellaripa, Francesco Boin, Deepak A. Rao   +9 more
wiley   +1 more source

Redox Pathogenesis in Rheumatic Diseases

ACR Open Rheumatology, Volume 6, Issue 6, Page 334-346, June 2024.
Despite being some of the most anecdotally well‐known roads to pathogenesis, the mechanisms governing autoimmune rheumatic diseases are not yet fully understood. The overactivation of the cellular immune system and the characteristic development of autoantibodies have been linked to oxidative stress.
Olivia T. Laniak, Thomas Winans, Akshay Patel, Joy Park, Andras Perl   +4 more
wiley   +1 more source

Myositis‐Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality

Arthritis &Rheumatology, Volume 76, Issue 6, Page 963-972, June 2024.
Objective Myositis‐associated autoantibodies (MAAs) have been associated with overlap myositis, certain disease manifestations such as interstitial lung disease (ILD), and worse prognosis in the idiopathic inflammatory myopathies. MAAs overall remain largely uncharacterized in patients with juvenile‐onset myositis.
Matthew A. Sherman, Payam Noroozi Farhadi, Katherine Pak, Edward P. Trieu, Kakali Sarkar, Ira N. Targoff, Megan L. Neely, Andrew L. Mammen, Lisa G. Rider, for the Childhood Myositis Heterogeneity Collaborative Study Group, Daniel A. Albert, Bita Arabshahi, Kaveh Ardalan, Alan N. Baer, Imelda M. Balboni, Susan H. Ballinger, Nastaran Bayat, Mara L. Becker, C. April Bingham, John F. Bohnsack, Victoria W. Cartwright, Randy Q. Cron, Rodolfo Curiel, Jason A. Dare, Marietta M. de Guzman, Fatma Dedeoglu, Paul J. DeMarco, Kaleo Eade, Barbara Anne Eberhard, Barbara S. Edelheit, Melissa E. Elder, Polly Ferguson, Terri H. Finkel, Robert C. Fuhlbrigge, Abraham Gedalia, Ellen A. Goldmuntz, Beth S. Gottlieb, Ricardo Guirola, William P. Hannan, Michael Henrickson, Patricia M. Hobday, Sandy Hong, Adam M. Huber, Anna Jansen, James Jarvis, Olcay Y. Jones, Ankur Kamdar, Hanna Kim, Susan Kim, Daniel J. Kingsbury, Takayuki Kishi, Bianca A. Lang, Melissa Lerman, Carol B. Lindsley, Frederick W. Miller, Stephen R. Mitchell, Kabita Nanda, Simona Nativ, Karen B. Onel, Wendy de la Pena, Maria D. Perez, Donald A. Person, Iago Pinal‐Fernandez, Tova Ronis, Sara E. Sabbagh, Adam Schiffenbauer, Heinrike Schmeling, Bracha Shaham, Susan Shenoi, Jennifer Soep, Matthew L. Stoll, Sangeeta Sule, Stacey E. Tarvin, Elizabeth Taylor‐Albert, Rita Volochayev, Dawn Wahezi, Patience H. White, Yongdong Zhao   +77 more
wiley   +1 more source

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia

ACR Open Rheumatology, Volume 6, Issue 4, Page 172-178, April 2024.
Objective Given fibromyalgia (FM) frequently co‐occurs with autoimmune disease, this study was initiated to objectively evaluate FM in a multiracial/ethnic cohort of patients with systemic lupus erythematosus (SLE). Methods Patients with SLE were screened for FM using the 2016 FM classification criteria during an in‐person rheumatologist visit.
Kelly Corbitt, Philip M. Carlucci, Brooke Cohen, Mala Masson, Amit Saxena, H. Michael Belmont, Chung‐E Tseng, Kamil E. Barbour, Heather Gold, Jill Buyon, Peter Izmirly   +10 more
wiley   +1 more source

Miocardiopatía restrictiva y comunicación interauricular en un paciente con esclerodermia Restrictive cardiomyopathy and atrial septal defect in a patient with scleroderma

Revista Cubana de Medicina, 2010
Se presentó un paciente con esclerodermia que se diagnosticó a partir de las manifestaciones cardiovasculares de la enfermedad: palpitaciones, disnea de esfuerzo, inflamación de manos y pies e incluso la cara.
Juan Valiente Mustelier, Julio Oscar Cabrera Rego, Raimyd García Fernández, Ana Martha López Mantecón   +3 more
doaj  

Esclerodermia

Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 2004
La esclerodermia es una alteración del tejido conectivo, que se caracteriza por un engrosamiento anormal de la piel. Generalmente se considera un desorden autoinmune.
Ana María Aristizábal Dávila, María Adelaida Echeverri Montaño, Francisco Vargas Carvajal, José Fernando Molina Restrepo, Luis Fernando Pinto Peñaranda, Ángela Zuluaga   +5 more
doaj  

[Characteristics of patients with systemic sclerosis who develop interstitial lung disease]. [PDF]

Rev Med Inst Mex Seguro Soc, 2023
Fajardo-Hermosillo LD, Ocampo-Torres MC, Rodríguez-Silverio J.   +2 more
europepmc   +1 more source

[Interstitial Lung Disease]. [PDF]

Open Respir Arch, 2023
Margallo Iribarnegaray J, Churruca Arróspide M, Matesanz López C, Pérez Rojo R.   +3 more
europepmc   +1 more source

Características clínicas y frecuencia de autoanticuerpos en pacientes con Lupus Eritematoso Sistémico que acuden al Hospital Nacional en el periodo 2018 -2023

Medicina Clínica y Social
Introducción: Lupus eritematoso sistémico (LES) se caracteriza por una disfunción del sistema inmunológico y presenta síntomas renales, dermatológicos, neuropsiquiátricos y cardiovasculares.
Luis Fernando Sánchez, Dora Montiel-Jarolin, Magali Jarolin Montiel, Margarita Samudio   +3 more
doaj   +1 more source

Isquemia distal en paciente con infección por SARS-CoV-2. [PDF]

FMC, 2023
Herraiz AM, García MPC, González CC.
europepmc   +1 more source